Piyasa kapalı· · EUR · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
European equities traded in the US as American depositary receipts were trending lower late Wednesda
Châtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years The BLA is supported by the results from the successful Phase 3 VITESSE trial – the largest immunotherapy clinical trial to date for this population. DBV has requested Priority Review of the BLA. DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, tod
European equities traded in the US as American depositary receipts were tracking slightly lower Thur
European equities traded in the US as American depositary receipts were tracking lower Wednesday mor
European equities traded in the US as American depositary receipts were heading lower late Friday mo
European equities traded in the US as American depositary receipts were rising sharply late Thursday
European equities traded in the US as American depositary receipts edged higher late Wednesday morni
European equities traded in the US as American depositary receipts were heading lower late Tuesday m
European equities traded in the US as American depositary receipts opened the week tracking sharply
European equities traded in the US as American depositary receipts were trending higher late Friday
European equities traded in the US as American depositary receipts were trending lower late Thursday
European equities traded in the US as American depositary receipts were marginally higher late Frida
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 DateTotal number of sharesTotal number of voting rights08/31/2026 314,388,807 Total gross of voting rights: 314,388,807 Total net* of voting rights: 314,222,095 * Net total = total number of voting rights attached to shares – shares without vo
European equities traded in the US as American depositary receipts were trending slightly higher lat
European equities traded in the US as American depositary receipts were marginally higher late Frida
European equities traded in the US as American depositary receipts were marginally higher late Tuesd
European equities traded in the US as American depositary receipts were tracking higher late Thursda
European equities traded in the US as American depositary receipts were trending lower in late Tuesd
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.